Nasenspray (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. By stimulating alpha receptors on the blood vessels of the nasal mucosa, it causes vasoconstriction, which reduces blood flow, decreases mucosal edema, and opens the nasal airway, providing rapid decongestion.

The appropriate dose of Nasenspray is determined by a qualified prescriber or pharmacist based on the patient’s age, condition, and response. Typically, a few sprays per nostril are used, but exact instructions should always follow the label or the healthcare professional’s guidance.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Nasenspray to weigh potential benefits against any unknown risks.

To order Nasenspray, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nasenspray’s active ingredient, Xylometazoline Hydrochloride, belongs to the imidazoline class, offering rapid vasoconstriction similar to phenylephrine but with a slightly longer duration of action. Compared with oxymetazoline, it has a comparable efficacy profile, though individual response and tolerability may vary.

Nasenspray should be stored at room temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the bottle tightly closed when not in use to maintain product stability and prevent contamination.

Nasenspray is applied directly into each nostril using the spray pump. The user should gently blow the nose, tilt the head slightly forward, insert the nozzle, and press the pump to deliver the recommended number of sprays. Avoid inhaling deeply during administration to limit systemic absorption.

The most serious risks include rebound congestion (rhinitis medicamentosa) after prolonged use, elevated blood pressure, tachycardia, and rare severe allergic reactions such as anaphylaxis. If any of these occur, discontinue use immediately and seek medical attention.

Nasenspray should be avoided by individuals with known hypersensitivity to Xylometazoline or any formulation components, patients with severe hypertension or uncontrolled cardiovascular disease, and children under six years of age unless directed by a healthcare professional.